CTLA4 and neoplasm: Apart from the inhibitory surface receptors CTLA-4 and PD-1 several cytoplasmic proteins, such as ubiquitin ligases and kinases, downstream of the T cell receptor (TCR) act as negative regulators of T cell activation and may limit anti-tumor immune responses.